- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05829902
Evaluation of an Herbal Extract on Sleep Parameters
Evaluation of an Herbal Extract on Sleep Parameters in Healthy, Middle-aged Women
The overall purpose of this interventional study is to investigate how a specific herbal extract influences the quality of sleep in middle-aged women with mild to moderate insomnia. During the study, the participants are asked to take the test drink every night for two weeks. Both objective (Oura ring) and subjective (analog sleep diaries, questionnaires) measures are included to evaluate sleep parameters as well as perceived alertness and impact on daily functions. The primary outcome is sleep onset latency (SOL), which is the time it takes for a person to fall asleep. Secondary outcomes which will be evaluated include time spent in different sleep stages, number of times waking up during the night, and various qualitative ratings of energy levels and mood during the day.
Researchers will compare the group with active product and placebo product to see if the consumption of the herbal extract will lead to improvements in the factors mentioned above.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lund, Sweden
- Aventure Clinical Trial Unit
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female
- Age 35-60
- BMI 18-30 kg/m2
- Mild to moderate insomnia according to the ISI (Insomnia Severity Index) questionnaire (ISI-value 10-21)
- Matching results from the Oura ring and sleep diaries during the run-in period
Exclusion Criteria:
- Metabolic disease (diabetes, cardiovascular disorders, hypo- or hyperthyroidism, etc)
- Severe psychiatric disorders
- Pregnancy, breastfeeding
- Restless legs or leg cramps that influence sleep and everyday life
- Conditions that prevent sleep through the symptoms that they produce (pain, nightly coughs, etc)
- Breathing problems (asthma, severe snoring, sleep apnea, etc)
- Medication that can influence sleep and/or wakefulness
- Consumption of herbal sedatives during the last month
- Having someone in the household that needs to be tended to during the night and pose a major risk to disturb the research participant's sleep to a large extent.
- Irregular work hours, including shift work at night
- Regularly sleeping more than 1 night per week away from home
- Tobacco or drug use
- Other factors that are deemed to influence participation negatively
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Active product
The active product is a drink consisting of 600 mg of lemon balm extract, tea leaves, brown sugar and powdered flavoring agent that is mixed with lukewarm water.
The volume per serving is 30 ml.
The drink will be taken every night before sleep for a period of two weeks.
|
30 ml drink containing 600 mg of lemon balm extract, tea leaves, brown sugar and flavoring agent, two weeks daily
|
|
Placebo Comparator: Placebo
The placebo drink is maltodextrin mixed with water, and the same tea leaves, brown sugar and powdered flavoring agent as the test drink.
The volume per serving is 30 ml.
The drink will be taken every night before sleep for a period of two weeks.
|
30 ml placebo drink containing maltodextrin, tea leaves, brown sugar and flavoring agent, two weeks daily
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep onset latency
Time Frame: 2 weeks
|
The length of time it takes a person to fall asleep when turning the lights off, this parameter will be measured by using the Oura Ring
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time spent in different sleep stages
Time Frame: 2 weeks
|
These Parameters will be measured by using the Oura Ring
|
2 weeks
|
|
Perceived alertness and wellbeing during the day
Time Frame: 2 weeks
|
These parameters will be measured by using a sleep diary (pen and paper) with a ranking scale which needs to be filled out in the morning and in the evening
|
2 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Sleepwell_2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Onset Latency
-
Nutrition Institute, SloveniaValens Int. d.o.o., Slovenija; Faculty of Pharmacy, University of Ljubljana... and other collaboratorsRecruitingSleep Quality | Sleep Onset LatencySlovenia
-
University of ArizonaNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting
-
The First Affiliated Hospital of Shanxi Medical...Shanxi Medical UniversityCompletedSleep Quality | Sleep Duration | Sleep Onset LatencyChina
-
University of ManitobaNot yet recruitingMEP Onset Latency
-
Institute of Nutrition, Slovenia (Nutris)Valens Int. d.o.o., Slovenija; Faculty of Pharmacy, University of Ljubljana... and other collaboratorsNot yet recruitingSleep Quality | Sleep Onset LatencySlovenia
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Bagcilar Training and Research HospitalCompleted
-
Brigham and Women's HospitalCompleted
-
University of Alabama at BirminghamTakedaCompletedADHD With Sleep Onset InsomniaUnited States
Clinical Trials on Herbal extract drink
-
University of UtahCompletedHyperglycemia | Hypertension | DyslipidemiaUnited States
-
TCI Co., Ltd.Completed
-
TCI Co., Ltd.Completed
-
TCI Co., Ltd.Completed
-
Unilever R&DCovance; PhytopharmCompletedOverweight | Body Weight | Appetite DepressantUnited States
-
Amway (China) R&D CenterRecruiting
-
University of ReadingCompleted
-
Korea Health Industry Development InstituteUnknown